Condition
Adjuvant Zinc May Increase the Efficacy of Botulinum Toxin
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Zinc Citrate 50 Mg
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Withdrawn1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Zinc Citrate 50 Mg1
Active Sponsors
- AbbVie1
- University of New Mexico1
Related Conditions
- Zinc Supplementation For Botulinum Toxin Treatment Of The Forehead1
- Adjuvant Oral Zinc And Botulinum Toxin1
- Botulinum Toxin Cosmetic1
- Glabellar Frown Lines1